메뉴 건너뛰기




Volumn 18, Issue 1, 2014, Pages 16-23

Mineralocorticoid receptor activation as an etiological factor in kidney diseases

Author keywords

Chronic kidney disease; Mineralocorticoid receptor; Proteinuria; Rac1; Salt sensitive hypertension

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; RAC1 PROTEIN; SODIUM CHLORIDE; AUTACOID; SALT INTAKE;

EID: 84896729310     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0827-3     Document Type: Review
Times cited : (9)

References (57)
  • 1
    • 84874644599 scopus 로고    scopus 로고
    • Clinical practice guideline for the evaluation and management of chronic kidney disease
    • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO
    • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):1-150.
    • (2012) Kidney Int Suppl , vol.2013 , Issue.3 , pp. 1-150
  • 2
    • 84880921602 scopus 로고    scopus 로고
    • Special issue: Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012
    • [Special issue: Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012]. Nihon Jinzo Gakkai Shi. 2012;54(8):1034-191.
    • (2012) Nihon Jinzo Gakkai Shi , vol.54 , Issue.8 , pp. 1034-1191
  • 3
    • 77953291706 scopus 로고    scopus 로고
    • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis
    • Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375(9731):2073-81.
    • (2010) Lancet , vol.375 , Issue.9731 , pp. 2073-2081
    • Matsushita, K.1    Van Der Velde, M.2    Astor, B.C.3    Woodward, M.4    Levey, A.S.5
  • 4
    • 79955622277 scopus 로고    scopus 로고
    • Mineralocorticoid receptor activation and blockade: An emerging paradigm in chronic kidney disease
    • 1:CAS:528:DC%2BC3MXltlyjuro%3D 21412221 10.1038/ki.2011.48
    • Bertocchio JP, Warnock DG, Jaisser F. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. Kidney Int. 2011;79(10):1051-60.
    • (2011) Kidney Int , vol.79 , Issue.10 , pp. 1051-1060
    • Bertocchio, J.P.1    Warnock, D.G.2    Jaisser, F.3
  • 5
    • 84868588459 scopus 로고    scopus 로고
    • Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A meta-analysis
    • 23013600 10.1016/S0140-6736(12)61272-0
    • Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380(9854):1649-61.
    • (2012) Lancet , vol.380 , Issue.9854 , pp. 1649-1661
    • Mahmoodi, B.K.1    Matsushita, K.2    Woodward, M.3    Blankestijn, P.J.4    Cirillo, M.5    Ohkubo, T.6
  • 6
    • 84865602423 scopus 로고    scopus 로고
    • Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study
    • 22717317 10.1016/S0140-6736(12)60572-8
    • Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012;380(9844):807-14.
    • (2012) Lancet , vol.380 , Issue.9844 , pp. 807-814
    • Tonelli, M.1    Muntner, P.2    Lloyd, A.3    Manns, B.J.4    Klarenbach, S.5    Pannu, N.6
  • 7
    • 79957827666 scopus 로고    scopus 로고
    • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
    • 1:CAS:528:DC%2BC3MXmvFyjsbs%3D 21289598 10.1038/ki.2010.550
    • Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79(12):1331-40.
    • (2011) Kidney Int , vol.79 , Issue.12 , pp. 1331-1340
    • Astor, B.C.1    Matsushita, K.2    Gansevoort, R.T.3    Van Der Velde, M.4    Woodward, M.5    Levey, A.S.6
  • 8
    • 79958817916 scopus 로고    scopus 로고
    • Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts
    • 1:CAS:528:DC%2BC3MXnsFKlsLg%3D 21289597 10.1038/ki.2010.531
    • Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93-104.
    • (2011) Kidney Int , vol.80 , Issue.1 , pp. 93-104
    • Gansevoort, R.T.1    Matsushita, K.2    Van Der Velde, M.3    Astor, B.C.4    Woodward, M.5    Levey, A.S.6
  • 9
    • 49149087718 scopus 로고    scopus 로고
    • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial
    • 1:CAS:528:DC%2BD1cXpvFKgsLs%3D 18707986 10.1016/S0140-6736(08)61236-2
    • Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547-53.
    • (2008) Lancet , vol.372 , Issue.9638 , pp. 547-553
    • Mann, J.F.1    Schmieder, R.E.2    McQueen, M.3    Dyal, L.4    Schumacher, H.5    Pogue, J.6
  • 10
    • 78650399880 scopus 로고    scopus 로고
    • Eplerenone in patients with systolic heart failure and mild symptoms
    • 1:CAS:528:DC%2BC3MXisValuw%3D%3D 21073363 10.1056/NEJMoa1009492
    • Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364(1):11-21.
    • (2011) N Engl J Med , vol.364 , Issue.1 , pp. 11-21
    • Zannad, F.1    McMurray, J.J.V.2    Krum, H.3    Van Veldhuisen, D.J.4    Swedberg, K.5    Shi, H.6
  • 11
    • 78649490387 scopus 로고    scopus 로고
    • Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome
    • 1:CAS:528:DC%2BC3cXhtFKjtrrK 20533072 10.1007/s10157-010-0298-8
    • Nagase M. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin Exp Nephrol. 2010;14(4):303-14.
    • (2010) Clin Exp Nephrol , vol.14 , Issue.4 , pp. 303-314
    • Nagase, M.1
  • 12
    • 79960972766 scopus 로고    scopus 로고
    • Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway
    • 1:CAS:528:DC%2BC3MXhtVejurrE 3148723 21765214 10.1172/JCI43124
    • Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest. 2011;121(8):3233-43.
    • (2011) J Clin Invest , vol.121 , Issue.8 , pp. 3233-3243
    • Shibata, S.1    Mu, S.2    Kawarazaki, H.3    Muraoka, K.4    Ishizawa, K.5    Yoshida, S.6
  • 13
    • 81155155589 scopus 로고    scopus 로고
    • Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies
    • 1:CAS:528:DC%2BC3MXhsVOis7vM 3217130 21945398 10.1016/j.steroids.2011.09. 004
    • Gomez-Sanchez CE, Warden M, Gomez-Sanchez MT, Hou X, Gomez-Sanchez EP. Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies. Steroids. 2011;76(14):1541-5.
    • (2011) Steroids , vol.76 , Issue.14 , pp. 1541-1545
    • Gomez-Sanchez, C.E.1    Warden, M.2    Gomez-Sanchez, M.T.3    Hou, X.4    Gomez-Sanchez, E.P.5
  • 14
    • 70349257487 scopus 로고    scopus 로고
    • Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure
    • 1:CAS:528:DC%2BD1MXpsleksrk%3D 19635989 10.1161/HYPERTENSIONAHA.109. 131110
    • Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension. 2009;54(3):537-43.
    • (2009) Hypertension , vol.54 , Issue.3 , pp. 537-543
    • Rickard, A.J.1    Morgan, J.2    Tesch, G.3    Funder, J.W.4    Fuller, P.J.5    Young, M.J.6
  • 15
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators
    • 1:CAS:528:DyaK1MXmtVyrurk%3D 10471456 10.1056/NEJM199909023411001
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med. 1999;341(10):709-17.
    • (1999) N Engl J Med , vol.341 , Issue.10 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6
  • 16
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • 1:CAS:528:DC%2BD3sXis1ehurY%3D 12668699 10.1056/NEJMoa030207
    • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309-21.
    • (2003) N Engl J Med , vol.348 , Issue.14 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3    Neaton, J.4    Martinez, F.5    Roniker, B.6
  • 17
    • 33751236177 scopus 로고    scopus 로고
    • Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus
    • 1:CAS:528:DC%2BD28XhtFCgsLvL 16901964 10.1210/en.2006-0944
    • Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, et al. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology. 2006;147(11):5363-73.
    • (2006) Endocrinology , vol.147 , Issue.11 , pp. 5363-5373
    • Guo, C.1    Martinez-Vasquez, D.2    Mendez, G.P.3    Toniolo, M.F.4    Yao, T.M.5    Oestreicher, E.M.6
  • 18
    • 33646366660 scopus 로고    scopus 로고
    • Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
    • 1:CAS:528:DC%2BD28XkvVKrsLs%3D 16571782 10.1681/ASN.2005111196
    • Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, et al. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol. 2006;17(5):1362-72.
    • (2006) J Am Soc Nephrol , vol.17 , Issue.5 , pp. 1362-1372
    • Han, S.Y.1    Kim, C.H.2    Kim, H.S.3    Jee, Y.H.4    Song, H.K.5    Lee, M.H.6
  • 19
    • 0031600240 scopus 로고    scopus 로고
    • Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats
    • 1:CAS:528:DyaK1cXptF2lsA%3D%3D 9453344 10.1161/01.HYP.31.1.451
    • Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension. 1998;31(1 Pt 2):451-8.
    • (1998) Hypertension , vol.31 , Issue.1 PART 2 , pp. 451-458
    • Rocha, R.1    Chander, P.N.2    Khanna, K.3    Zuckerman, A.4    Stier, C.T.5
  • 20
    • 0242366540 scopus 로고    scopus 로고
    • Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
    • 1:CAS:528:DC%2BD3sXjslygsb4%3D 12675855 10.1046/j.1523-1755.2003.00929.x
    • Blasi ER, Rocha R, Rudolph AE, Blomme EAG, Polly ML, Mcmahon EG. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003;63(5):1791-800.
    • (2003) Kidney Int , vol.63 , Issue.5 , pp. 1791-1800
    • Blasi, E.R.1    Rocha, R.2    Rudolph, A.E.3    Blomme, E.A.G.4    Polly, M.L.5    McMahon, E.G.6
  • 21
    • 58149145611 scopus 로고    scopus 로고
    • Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats
    • 18923385 10.1038/ki.2008.507
    • Ikeda H, Tsuruya K, Toyonaga J, Masutani K, Hayashida H, Hirakata H, et al. Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats. Kidney Int. 2008;75(2):147-55.
    • (2008) Kidney Int , vol.75 , Issue.2 , pp. 147-155
    • Ikeda, H.1    Tsuruya, K.2    Toyonaga, J.3    Masutani, K.4    Hayashida, H.5    Hirakata, H.6
  • 22
    • 33845238078 scopus 로고    scopus 로고
    • Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors
    • 1:CAS:528:DC%2BD28XhtlGiu7bI 17082236 10.1681/ASN.2006080944
    • Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, et al. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol. 2006;17(12):3438-46.
    • (2006) J Am Soc Nephrol , vol.17 , Issue.12 , pp. 3438-3446
    • Nagase, M.1    Yoshida, S.2    Shibata, S.3    Nagase, T.4    Gotoda, T.5    Ando, K.6
  • 23
    • 80055060496 scopus 로고    scopus 로고
    • The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomerulonephritis
    • 1:CAS:528:DC%2BC3MXhtFGkt73L 3160612 21904636
    • Zitt E, Eller K, Huber JM, Kirsch AH, Tagwerker A, Mayer G, et al. The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomerulonephritis. Int J Clin Exp Pathol. 2011;4(6):606-15.
    • (2011) Int J Clin Exp Pathol , vol.4 , Issue.6 , pp. 606-615
    • Zitt, E.1    Eller, K.2    Huber, J.M.3    Kirsch, A.H.4    Tagwerker, A.5    Mayer, G.6
  • 24
    • 20144369870 scopus 로고    scopus 로고
    • Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis
    • 1:CAS:528:DC%2BD2MXjvVGhtb4%3D 15894838 10.1291/hypres.27.971
    • Asai M, Monkawa T, Marumo T, Fukuda S, Tsuji M, Yoshino J, et al. Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis. Hypertens Res. 2004;27(12):971-8.
    • (2004) Hypertens Res , vol.27 , Issue.12 , pp. 971-978
    • Asai, M.1    Monkawa, T.2    Marumo, T.3    Fukuda, S.4    Tsuji, M.5    Yoshino, J.6
  • 26
    • 77950515108 scopus 로고    scopus 로고
    • Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome
    • 1:CAS:528:DC%2BC3MXps1OmsL4%3D 20470301 10.1111/j.1440-1797.2009.01256.x
    • Fukuda A, Fujimoto S, Iwatsubo S, Kawachi H, Kitamura K. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome. Nephrology. 2010;15(3):321-6.
    • (2010) Nephrology , vol.15 , Issue.3 , pp. 321-326
    • Fukuda, A.1    Fujimoto, S.2    Iwatsubo, S.3    Kawachi, H.4    Kitamura, K.5
  • 27
    • 41149157892 scopus 로고    scopus 로고
    • Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome
    • 1:CAS:528:DC%2BD1cXjsFyltrw%3D 18094029 10.1152/ajprenal.00524.2007
    • Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, et al. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Am J Physiol Renal Physiol. 2008;294(3):F628-37.
    • (2008) Am J Physiol Renal Physiol , vol.294 , Issue.3
    • Nakhoul, F.1    Khankin, E.2    Yaccob, A.3    Kawachi, H.4    Karram, T.5    Awaad, H.6
  • 28
    • 39049092072 scopus 로고    scopus 로고
    • Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium
    • 1:CAS:528:DC%2BD1cXivFKqt7w%3D 18184857 10.1681/ASN.2007050531
    • Terada Y, Kuwana H, Kobayashi T, Okado T, Suzuki N, Yoshimoto T, et al. Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. J Am Soc Nephrol. 2008;19(2):298-309.
    • (2008) J Am Soc Nephrol , vol.19 , Issue.2 , pp. 298-309
    • Terada, Y.1    Kuwana, H.2    Kobayashi, T.3    Okado, T.4    Suzuki, N.5    Yoshimoto, T.6
  • 30
    • 84855183026 scopus 로고    scopus 로고
    • Focal segmental glomerulosclerosis
    • 22187987 10.1056/NEJMra1106556
    • D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398-411.
    • (2011) N Engl J Med , vol.365 , Issue.25 , pp. 2398-2411
    • D'Agati, V.D.1    Kaskel, F.J.2    Falk, R.J.3
  • 31
    • 84857243208 scopus 로고    scopus 로고
    • Cell biology and pathology of podocytes
    • 1:CAS:528:DC%2BC38XjvFyntro%3D 3600372 22054238 10.1146/annurev-physiol- 020911-153238
    • Greka A, Mundel P. Cell biology and pathology of podocytes. Annu Rev Physiol. 2012;74:299-323.
    • (2012) Annu Rev Physiol , vol.74 , pp. 299-323
    • Greka, A.1    Mundel, P.2
  • 32
    • 67649850328 scopus 로고    scopus 로고
    • Aldosterone induces apoptosis in rat podocytes: Role of PI3-K/Akt and p38MAPK signaling pathways
    • 1:CAS:528:DC%2BD1MXhtVCgurjP 19590239 10.1159/000228080
    • Chen C, Liang W, Jia J, van Goor H, Singhal PC, Ding G. Aldosterone induces apoptosis in rat podocytes: role of PI3-K/Akt and p38MAPK signaling pathways. Nephron Exp Nephrol. 2009;113(1):e26-34.
    • (2009) Nephron Exp Nephrol , vol.113 , Issue.1
    • Chen, C.1    Liang, W.2    Jia, J.3    Van Goor, H.4    Singhal, P.C.5    Ding, G.6
  • 33
    • 79959238107 scopus 로고    scopus 로고
    • Mitochondrial dysfunction mediates aldosterone-induced podocyte damage
    • 1:CAS:528:DC%2BC3MXntVyrt7o%3D 21514419 10.1016/j.ajpath.2011.01.029
    • Zhu C, Huang S, Yuan Y, Ding G, Chen R, Liu B, et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage. Am J Pathol. 2011;178(5):2020-31.
    • (2011) Am J Pathol , vol.178 , Issue.5 , pp. 2020-2031
    • Zhu, C.1    Huang, S.2    Yuan, Y.3    Ding, G.4    Chen, R.5    Liu, B.6
  • 34
    • 84896699306 scopus 로고    scopus 로고
    • Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury
    • 1:CAS:528:DC%2BC38XosF2qsbY%3D
    • Yuan Y, Huang S, Wang W, Wang Y, Zhang P, Zhu C, et al. Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. Kidney Int. 2012;30:1-19.
    • (2012) Kidney Int , vol.30 , pp. 1-19
    • Yuan, Y.1    Huang, S.2    Wang, W.3    Wang, Y.4    Zhang, P.5    Zhu, C.6
  • 35
    • 84863532164 scopus 로고    scopus 로고
    • Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury
    • 1:CAS:528:DC%2BC38XhtFOks7vI 22652704 10.1681/ASN.2011100985
    • Ogawa Y, Mukoyama M, Yokoi H, Kasahara M, Mori K, Kato Y, et al. Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J Am Soc Nephrol. 2012;23(7):1198-209.
    • (2012) J Am Soc Nephrol , vol.23 , Issue.7 , pp. 1198-1209
    • Ogawa, Y.1    Mukoyama, M.2    Yokoi, H.3    Kasahara, M.4    Mori, K.5    Kato, Y.6
  • 36
    • 34047223424 scopus 로고    scopus 로고
    • Early aldosterone-induced gene product regulates the epithelial sodium channel by deubiquitylation
    • 1:CAS:528:DC%2BD2sXkslSrs7g%3D 17344426 10.1681/ASN.2006080902
    • Fakitsas P, Adam G, Daidié D, van Bemmelen MX, Fouladkou F, Patrignani A, et al. Early aldosterone-induced gene product regulates the epithelial sodium channel by deubiquitylation. J Am Soc Nephrol. 2007;18(4):1084-92.
    • (2007) J Am Soc Nephrol , vol.18 , Issue.4 , pp. 1084-1092
    • Fakitsas, P.1    Adam, G.2    Daidié, D.3    Van Bemmelen, M.X.4    Fouladkou, F.5    Patrignani, A.6
  • 37
    • 79961096910 scopus 로고    scopus 로고
    • Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production
    • 1:CAS:528:DC%2BC3MXps1ykt7c%3D 21220752 10.1093/ndt/gfq750
    • Toyonaga J, Tsuruya K, Ikeda H, Noguchi H, Yotsueda H, Fujisaki K, et al. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Nephrol Dial Transplant. 2011;26(8):2475-84.
    • (2011) Nephrol Dial Transplant , vol.26 , Issue.8 , pp. 2475-2484
    • Toyonaga, J.1    Tsuruya, K.2    Ikeda, H.3    Noguchi, H.4    Yotsueda, H.5    Fujisaki, K.6
  • 38
    • 57349168398 scopus 로고    scopus 로고
    • Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease
    • 1:CAS:528:DC%2BD1cXhsVWgsr7L 19029984 10.1038/nm.1879
    • Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med. 2008;14(12):1370-6.
    • (2008) Nat Med , vol.14 , Issue.12 , pp. 1370-1376
    • Shibata, S.1    Nagase, M.2    Yoshida, S.3    Kawarazaki, W.4    Kurihara, H.5    Tanaka, H.6
  • 39
    • 33846443625 scopus 로고    scopus 로고
    • Podocyte as the target for aldosterone: Roles of oxidative stress and SGK1
    • 10.1161/01.HYP.0000255636.11931.a2
    • Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and SGK1. Hypertension. 2006;49(2):355-64.
    • (2006) Hypertension , vol.49 , Issue.2 , pp. 355-364
    • Shibata, S.1    Nagase, M.2    Yoshida, S.3    Kawachi, H.4    Fujita, T.5
  • 40
    • 84861832781 scopus 로고    scopus 로고
    • Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation
    • 1:CAS:528:DC%2BC38XpvFCisr0%3D 22440899 10.1681/ASN.2011070734
    • Kawarazaki W, Nagase M, Yoshida S, Takeuchi M, Ishizawa K, Ayuzawa N, et al. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. J Am Soc Nephrol. 2012;23(6):997-1007.
    • (2012) J Am Soc Nephrol , vol.23 , Issue.6 , pp. 997-1007
    • Kawarazaki, W.1    Nagase, M.2    Yoshida, S.3    Takeuchi, M.4    Ishizawa, K.5    Ayuzawa, N.6
  • 41
    • 84864245115 scopus 로고    scopus 로고
    • Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats
    • 1:CAS:528:DC%2BC38XhtFWisbvN 3404044 22911865 10.1371/journal.pone. 0041896
    • Kitada K, Nakano D, Liu Y, Fujisawa Y, Hitomi H, Shibayama Y, et al. Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats. PLoS One. 2012;7(7):e41896.
    • (2012) PLoS One , vol.7 , Issue.7 , pp. 41896
    • Kitada, K.1    Nakano, D.2    Liu, Y.3    Fujisawa, Y.4    Hitomi, H.5    Shibayama, Y.6
  • 42
    • 84856113013 scopus 로고    scopus 로고
    • Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: Role of small GTPase Rac1
    • 1:CAS:528:DC%2BC38Xns1arsw%3D%3D 22232135 10.1161/HYPERTENSIONAHA.111. 185520
    • Nagase M, Ayuzawa N, Kawarazaki W, Ishizawa K, Ueda K, Yoshida S, et al. Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: role of small GTPase Rac1. Hypertension. 2012;59(2):500-6.
    • (2012) Hypertension , vol.59 , Issue.2 , pp. 500-506
    • Nagase, M.1    Ayuzawa, N.2    Kawarazaki, W.3    Ishizawa, K.4    Ueda, K.5    Yoshida, S.6
  • 43
    • 34748859681 scopus 로고    scopus 로고
    • The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease
    • 1:CAS:528:DC%2BD2sXht1ahsr3E 2034302 17878513 10.1124/pr.59.3.3
    • Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59(3):251-87.
    • (2007) Pharmacol Rev , vol.59 , Issue.3 , pp. 251-287
    • Kobori, H.1    Nangaku, M.2    Navar, L.G.3    Nishiyama, A.4
  • 44
    • 20544453256 scopus 로고    scopus 로고
    • Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage
    • 1:CAS:528:DC%2BD2MXkvVCmu7o%3D 15939810 10.1161/CIRCULATIONAHA.104.521625
    • Fiebeler A, Nussberger J, Shagdarsuren E, Rong S, Hilfenhaus G, Al-Saadi N, et al. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation. 2005;111(23):3087-94.
    • (2005) Circulation , vol.111 , Issue.23 , pp. 3087-3094
    • Fiebeler, A.1    Nussberger, J.2    Shagdarsuren, E.3    Rong, S.4    Hilfenhaus, G.5    Al-Saadi, N.6
  • 45
    • 64949189157 scopus 로고    scopus 로고
    • Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt
    • 1:CAS:528:DC%2BD1MXks1Sjs7o%3D 2770712 19225557 10.1038/ki.2009.9
    • Lea WB, Kwak ES, Luther JM, Fowler SM, Wang Z, Ma J, et al. Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int. 2009;75(9):936-44.
    • (2009) Kidney Int , vol.75 , Issue.9 , pp. 936-944
    • Lea, W.B.1    Kwak, E.S.2    Luther, J.M.3    Fowler, S.M.4    Wang, Z.5    Ma, J.6
  • 46
    • 66149131479 scopus 로고    scopus 로고
    • Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis
    • 1:CAS:528:DC%2BD1MXktFKis78%3D 19261819 10.2215/CJN.04750908
    • Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4(3):542-51.
    • (2009) Clin J Am Soc Nephrol , vol.4 , Issue.3 , pp. 542-551
    • Navaneethan, S.D.1    Nigwekar, S.U.2    Sehgal, A.R.3    Strippoli, G.F.4
  • 48
    • 33750274950 scopus 로고    scopus 로고
    • Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function
    • 17053552 10.1097/01.hjh.0000249708.44016.5c
    • van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, et al. Spironolactone in type 2 diabetic nephropathy: effects on proteinuria, blood pressure and renal function. J Hypertens. 2006;24(11):2285-92.
    • (2006) J Hypertens , vol.24 , Issue.11 , pp. 2285-2292
    • Van Den Meiracker, A.H.1    Baggen, R.G.2    Pauli, S.3    Lindemans, A.4    Vulto, A.G.5    Poldermans, D.6
  • 49
    • 33845302661 scopus 로고    scopus 로고
    • Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
    • 1:CAS:528:DC%2BD28Xht1Kju7bL 17035949
    • Bianchi S, Bigazzi R, Campese VM. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int. 2006;70(12):2116-23.
    • (2006) Kidney Int , vol.70 , Issue.12 , pp. 2116-2123
    • Bianchi, S.1    Bigazzi, R.2    Campese, V.M.3
  • 50
    • 33746558934 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
    • 1:CAS:528:DC%2BD28Xjs1GrtLk%3D 17699214 10.2215/CJN.01040905
    • Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin J Am Soc Nephrol. 2006;1(2):256-62.
    • (2006) Clin J Am Soc Nephrol , vol.1 , Issue.2 , pp. 256-262
    • Chrysostomou, A.1    Pedagogos, E.2    Macgregor, L.3    Becker, G.J.4
  • 51
    • 72049109463 scopus 로고    scopus 로고
    • Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy
    • 1:CAS:528:DC%2BD1MXhs1Witb3P 19926893 10.1681/ASN.2009070737
    • Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol. 2009;20(12):2641-50.
    • (2009) J Am Soc Nephrol , vol.20 , Issue.12 , pp. 2641-2650
    • Mehdi, U.F.1    Adams-Huet, B.2    Raskin, P.3    Vega, G.L.4    Toto, R.D.5
  • 52
    • 31544477239 scopus 로고    scopus 로고
    • Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts
    • 1:CAS:528:DC%2BD2MXhtVektr7L 16087786 10.1161/01.HYP.0000174593.88899.68
    • Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension. 2005;46(4):1039-45.
    • (2005) Hypertension , vol.46 , Issue.4 , pp. 1039-1045
    • Nagai, Y.1    Miyata, K.2    Sun, G.P.3    Rahman, M.4    Kimura, S.5    Miyatake, A.6
  • 53
    • 20144365498 scopus 로고    scopus 로고
    • Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability
    • 1:CAS:528:DC%2BD2MXisV2jtLc%3D 15699469 10.1161/01.HYP.0000154681.38944. 9a
    • Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K, et al. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension. 2005;45(4):710-6.
    • (2005) Hypertension , vol.45 , Issue.4 , pp. 710-716
    • Nishiyama, A.1    Yao, L.2    Fan, Y.3    Kyaw, M.4    Kataoka, N.5    Hashimoto, K.6
  • 55
    • 84868662652 scopus 로고    scopus 로고
    • Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors
    • 1:CAS:528:DC%2BC38Xht1GhsbnP 3491085 22922412 10.1038/nm.2891
    • McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med. 2012;18(9):1429-33.
    • (2012) Nat Med , vol.18 , Issue.9 , pp. 1429-1433
    • McCurley, A.1    Pires, P.W.2    Bender, S.B.3    Aronovitz, M.4    Zhao, M.J.5    Metzger, D.6
  • 57
    • 84862737919 scopus 로고    scopus 로고
    • Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis
    • 1:CAS:528:DC%2BC38XpsFWnsrs%3D 22653557 10.1210/en.2011-2098
    • Bienvenu LA, Morgan J, Rickard AJ, Tesch GH, Cranston GA, Fletcher EK, et al. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis. Endocrinology. 2012;153(7):3416-25.
    • (2012) Endocrinology , vol.153 , Issue.7 , pp. 3416-3425
    • Bienvenu, L.A.1    Morgan, J.2    Rickard, A.J.3    Tesch, G.H.4    Cranston, G.A.5    Fletcher, E.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.